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Introduction
The relationship between membrane permeability and pH can reveal the extent of the contribution from several effects relevant to drug absorption/distribution, such as aqueous boundary layer (ABL) resistance, paracellular leakage, and drug ionization (Ho et al., 2000) , including those related to carrier-mediated/facilitated transport (Thomson and Dietschy, 1977; Tsuji et al., 1994; Takanaga et al., 1994) .
The mammalian intestinal barrier (Wilson, 1967; Högerle and Winne, 1983; Kararli, 1995; Collett et al., 1997; Desesso and Williams, 2008) possesses variable pH gradients (acidic on the luminal side, neutral on the blood side). So, it is not so uncommon to find studies of drug transport as a function of pH -most obviously, to mimic the physiological pH conditions, but more subtly, to tease out contributions to transport from several biophysical factors (Ho et al., 2000) . For example, there have been many published in vitro studies using cell lines (e.g., Caco-2, MDCK), or primary cell cultures (e.g., porcine brain capillary endothelium), where permeability was measured at two different pH values in the interval 5.4-7.4, under gradient-pH and/or isopH conditions (Adson et al., 1995; Pade and Stavchansky, 1985; Raeissi et al., 1999; Yamashita et al., 2000; Laitinen et al., 2003; Alsenz and Haenel, 2003; Lee et al., 2005; Bhardwaj et al., 2005; Berginc et al., 2007; Kanaan et al., 2008) . A few studies have been published where 3-4 different pH values were considered Yu and Zeng, 2007; Agarwal et al., 2007; Korjamo et al., 2008; Yusof et al., 2014) . The most comprehensive in vitro investigations, with up to nine different pH values per molecule considered, were reported by Artursson and coworkers (Palm et al., 1999; Neuhoff et al., 2003 Neuhoff et al., , 2005 Avdeef et al., 2005) . Principally, these pH-dependent studies focused on modeling the intestinal barrier, with one exception (Yusof et al., 2014) . Controls were included in the assays to confirm that the biological barrier stayed intact as a result of pH changes.
In contrast to the intestinal environment, the in vivo blood-brain barrier (BBB) has no appreciable pH gradient between the luminal and the abluminal sides. It may not appear obvious that in vivo studies of BBB permeability as a function of pH have any practical relevance. Indeed, there could be concern that non-physiological pH might disrupt the tightly-regulated BBB. As it turns out, the BBB can withstand a range of pH values, provided the exposure time is short. For example, Greenwood et al. (1989) saw no significant mannitol permeability increase when a pH 5.5 lactic acid solution was perfused through rat brain for 450 s. In the 30-s in situ rat brain perfusion study of several highly lipophilic drugs (amitriptyline, atomoxetine, imipramine, maprotiline, sertraline, indomethacin) in pH 5.5-8.5 buffers, physical integrity of the BBB was confirmed using markers (moderately permeable antipyrine and low-permeable atenolol) co-perfused in the samplecontaining buffers .
With the possible opportunities to deconvolve/quantify several factors affecting BBB transport (e.g., impact of cerebral perfusion fluid flow on assessment of lipophilic drug uptake, native/disease-state paracellular leakage, carrier-mediated/facilitated effects), surprisingly only a hand-full of pH-dependent in vivo studies of transport at the BBB have been reported (Suzuki et al., 2002a (Suzuki et al., , 2002b (Suzuki et al., , 2010a Okura et al., 2008; Avdeef and Sun, 2011; Suzuki et al., 2016) . Efficient computational tools to comprehensively evaluate such pH-dependent data have not been widely applied (Yusof et al., 2014) .
In this study, we exploit what has been learned from the pH-dependent in vitro cell-based biophysical models (sharpened by intestinal applications), and apply such models to the novel mechanistic analysis of the published pH-dependent in vivo data for pentazocine (Suzuki et al., 2002a (Suzuki et al., , 2002b , naloxone (Suzuki et al., 2010a) , and oxycodone (Okura et al., 2008) , to illustrate the potential value of pH modulation for in vivo BBB assays. Preliminary treatment of oxycodone data has been described . In the case of naloxone, a pHdependent Michaelis-Menten equation (pH-MME) analysis indicated a smooth sigmoidal transition from a cation CM uptake process (pH 5.5-7.0) to a neutral-species CM uptake process (pH 8.0-8.5), with near equal contribution from both types at pH 7.4. The pCEL-X program (Yusof et al., 2014) used in the study was further expanded to accommodate new computational features related to carrier-mediated (CM) transport.
Materials and methods

Data sources
The data used here to illustrate the impact of capillary flow hydrodynamics on carrier-mediated transport of the opioid derivatives were from Suzuki et al. (2002a Suzuki et al. ( , 2002b Suzuki et al. ( , 2010a and Okura et al. (2008) . Table 1 lists the physicochemical properties of the three drugs studied. Table 2 lists the data taken from the original sources, but converted to capillary-based apparent permeability values as a function of pH.
Biophysical model
In vitro cell monolayers grown to confluence on porous filters have been used to model drug absorption properties of the in vivo cell membrane barriers. Such models factor in a number of effects, including (i) the resistance of the aqueous boundary layer (ABL) at the interface between the aqueous solution and the cell surface, (ii) the paracellular leakiness of the cell junctions, and (iii) the pH of the solution. Appendix A describes the equations applied to in vitro cell monolayer data analyses. Appendix B extends the construct to in vivo models of uptake at the BBB from perfusate/injectate flow in brain capillaries.
By way of introduction to the computational approach, a simple electrical circuit may be considered. In the circuit analogy, resistance and permeability are related inversely. In a series circuit, the total resistance is the sum of the individual resistances. In a parallel circuit, the total permeability is the sum of the permeabilities of each parallel path. For example, consider that a molecular transport barrier consists of three lamellae: (a) luminal aqueous boundary layer (ABL1), (b) layer of cells bound together very tightly (CELL), and (c) abluminal aqueous boundary (ABL2). The total resistance to transport would be: R TOT = R ABL1 + R CELL + R ABL2 . In permeability terms, 1/P TOT = 1/ P ABL1 + 1/P CELL + 1/P ABL2 . Usually, the measured ABL permeability implicitly includes both ABL layers (since it is difficult to measure individual contributions), as 1/P ABL = 1/P ABL1 + 1/P ABL2 . Next, consider a cell barrier with leaky junctions, so that there are two parallel paths a molecule may take: paracellular (para) and transcellular (C). In permeability terms, 1/P TOT = 1/P ABL + 1/(P C + P para ). This simple analogy is the basis for the biophysical model described here, as elaborated in the appendices. So, when a diffusion path is in series through several sequential diffusion barriers (e.g., aqueous boundary layer plus a cell monolayer), the total inverse permeability is the sum of the individual inverse permeabilities. This is denoted by Eq. (A.1) in Appendix A. The last term in Eq. (A.1) exemplifies parallel resistances, where permeability is additive. This is where the same diffusion layer has contiguous patches of different permeability (e.g., transcellular plus paracellular paths). Fig. 1 illustrates a typical plot of logarithmic permeability as a function of pH. The in vitro and in vivo curves are very similar. The caption in Fig. 1 describes the different components. The filter contribution, which would be relevant only to the in vitro case, is not shown. The filter permeability curve would be a line parallel to the ABL permeability line, but above it as in the case of translucent polycarbonate filters, but not necessarily of clear plastic polyethylene filters (Yusof et al., 2014) .
As can be seen in Fig. 1 , the apparent permeability of ionizable molecules depends on pH, and the shapes of the permeability-pH profiles can be theoretically predicted when the pK a of the molecule is known, the pH-partition hypothesis is valid, and the resistance of the ABL is not neglected. There are opportunities to apply some elements of these planar biophysical models to study the drug penetration properties in the capillary environment of the blood-brain barrier (BBB). The pK a = 9.0, P 0 = 10 − 2 cm•s
For comparison of the two hydrodynamic models, the calculation assumed log P ABL = − 3.40 (same as log (F pf /S)). The thick solid curve represents log P app (= log (K in / S = log (k d /S))); see text. The dash-dot-dot curve denotes where the monolayer model departs from the capillary model. The dashed curve represents the transcellular membrane permeability due to the uncharged species, according to the pH-partition hypothesis. It also may include the contribution due to a CM process affecting the neutral species. The dash-dot curve is due to paracellular permeability. The horizontal dotted line indicates the permeability limit due to the hydrodynamic effects (flow limit or ABL). The P app curves have a slope of 1 before the central bend and a slope of zero after the bend. The pH in the middle of the central bend is called pK a flux , where 50% of the permeation is due to transcellular membrane permeability and 50% due to the apparent/effective permeability as a consequence of the hydrodynamic effect. The intrinsic permeability can be estimated for ionizable flow-limited molecules (i.e., P 0 > > F pf /S) from log P 0 = log (F pf /S) + |pK a − pK a flux |. The dynamic range window (DRW) defines where permeability can be directly measured. The DRW ceiling is the flow/ABL limit; its floor is the paracellular limit.
appendices summarize the computational details underpinning the case studies described in the Results and discussion section. In the rodent in situ brain perfusion (ISBP) technique, the traditional method used to determine cerebral blood flow rate, F pf (cf., Eq. (B.3)), of highly permeable compounds is based on the flow marker diazepam (Takasato et al., 1984; Smith, 2003) . Sometimes uptake studies are reported with cerebral blood flow F pf values taken from earlier published studies, with the assumption that once determined, the values are re-usable in subsequent studies in the same animal model.
An alternative method for correcting for cerebral flow was developed by Avdeef and Sun (2011) . Provided that K in (cf., Eq. (B.3)) values are determined at several values of perfusate pH, the highly-permeable drug itself can serve as a flow marker, in a procedure described as the pH-dependent Crone-Renkin (pH-CRE) method in Appendix B.
Computational tool for in vitro/in vivo permeability analysis
A weighted nonlinear regression method (Avdeef, 2012; Yusof et al., 2014) was used to analyze the terms in the planar monolayer Eq. (A.1) and the capillary flow Eq. (B.10). The pCEL-X v4.0 program (in-ADME Research) was used to determine the Michaelis-Menten parameters J max , K m , and k d (using experimentally weighted data -see Abbreviations for definitions of terms), and the paracellular parameters ε/δ, (ε/δ) 2 , R, Δφ and h ABL (which apply to both planar and capillary cases), based on the logarithmic form of Eq. (A.1). The program was also used to determine the F pf , P 0 and, where possible, P + or P para (but not both) by the capillary flow pH-CRE method (Eq. (B.10)). The analytical partial derivatives of the log K in unidirectional transfer function with respect to the refinable parameters F pf , P 0 , P + , and P para are calculated explicitly, based on standard mathematical techniques. The function minimized during refinement is the sum of weighted residuals, as previously described (Avdeef, 2012) . The goodness-of-fit (GOF), the root-meansquare of the minimized function, is used as a quality of fit index. Ideally, GOF has the expectation value of 1.0 if the experimental errors in the dependent variables used in the regression are reliable (and scaled accordingly) and the model is appropriate.
Assumptions made
The opioids considered here show complicated uptake mechanisms at the BBB, involving carrier-mediation (CM) as well as lipoidal passive diffusion (PD). The analyses presented here draw on the assumptions: (i) uptake into the brain (across the BBB) can involve both CM and PD processes; (ii) in the PD process, the pH partition hypothesis is valid, namely, that only the neutral species can cross the BBB (i.e., cationic opioids assumed not to cross the BBB by PD); (iii) for the lipophilic opioids, paracellular transport is inconsequential at the BBB (due to the tight junctions); (iv) the ABL resistance is negligible under brain capillary fluid flow conditions; (v) the lipophilic opioids cannot permeate the BBB, either by PD or CM, at a velocity greater than that of the cerebral capillary fluid flow (i.e., K in ≤ F pf ); (vi) the effect of efflux is not explicitly considered (i.e., where possible, data with very low injectate/perfusate concentrations were excluded in the MM analyses).
Results and discussion
Oxycodone cerebral blood flow rate from pH-dependent Crone-Renkin equation (pH-CRE)
A case study in pH dependence at the BBB is illustrated by the opioid agonist, oxycodone (Okura et al., 2008) . There is evidence that the drug is subject to carrier-mediated uptake by the pyrilamine transporter, a putative organic cation energy-dependent H + -coupled antiporter. The rat ISBP data were measured at a flow rate of 4.9 mL·min − 1 , at both pH 7.4 and 8.4, with uptake determined at several time points over a 30-s interval. Since the cerebral flow rate was not available in the study, the authors used an earlier-published value, F pf = 0.1256 mL·s Takasato et al., 1984) . This cerebral flow rate suggests that oxycodone uptake would not be flow-limited in the perfusion experiment (i.e., based on the above F pf , log (F pf /S) = −2.90 is well above the highest point in Fig. 2 ). However, since K in values were measured at two different pH values in the Okura et al. study, the data could be re-analyzed by the new pH-CRE method. Fig. 2 shows the results of such an analysis. An accurately measured pK a 8.73 of oxycodone at 37°C was used (Table 1) . Oxycodone is 96% and 68% positively charged at pH 7.4 and 8.4, respectively. For the inhibited and uninhibited cases in the figure, the pH-CRE F pf values (represented by the dotted lines) are nearly identical, and are 7-fold lower than the assumed value.
In Fig. 2 , the upper curve with the circle symbols represents the perfusion-derived log P app as a function of pH in the absence of inhibitors. The apparent intrinsic permeability is 908 × 10 − 6 cm·s − 1 . This is the value determined using Eq. (B.10) applied to the two measurements done in the absence of inhibitor, and includes contributions from both CM and PD processes. If F pf = 0.1256 mL·s − 1 ·g − 1 is used in place of the determined value (0.020 mL·s
), then the apparent intrinsic value decreases to 574 × 10 − 6 cm·s − 1 . In the presence of 1 mM pyrilamine (as inhibitor), the permeability decreases at both pH, as indicated by the curve with the square symbols, confirming that oxycodone is a substrate of a pyrilamine transporter. The purely passive intrinsic permeability value was determined to be 398 × 10 − 6 cm·s − 1 (=log P 0 -3.40 from Eq. (B.10) applied to the two points measured in the presence of inhibitor). If F pf = 0.1256 mL·s − 1 ·g − 1 is used in place of the determined value (0.016 mL·s
), then the intrinsic value decreases to 354 × 10 − 6 cm·s − 1
. The difference between the two P 0 values is not big because the apparent permeability values are well below the flow limit in the inhibited case.
If one assumes that CM transport contribution is entirely eliminated by 1 mM pyrilamine, the analysis by the pH-CRE method suggests that in the absence of inhibitor, a CM process increases the permeability of the uncharged species by a factor of 2.3 (=908/398), implying that the transporter appears to facilitate the uptake of the neutral form of the drug. This is suggested by the parallel displacement of the two curves in the pH 7.4-8.4 interval as the result of added inhibitor. Given that the Fig. 2 . pH-Dependent Crone-Renkin equation analysis of rat in situ brain perfusion (ISBP) data of oxycodone. The lower (blue) solid curve is the best fit to the data measured in the presence of 1 mM pyrilamine (as inhibitor). The upper (red) curve represents the assay results in the absence of inhibitor. The uptake was mildly flow limited for both the withand without-inhibitor data sets, with nearly the same F pf values of 0.020 (without inhibitor) and 0.016 (with 1 mM pyrilamine inhibitor) mL·s
. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) S.R. Yusof et al. European Journal of Pharmaceutical Sciences 106 (2017) 274-286 pK a of oxycodone is 8.73, it was not possible to fit the pH 7.4 and 8.4 data with permeability coefficient of the cationic species (P + ). Consequently, the action of the transporter on the cationic form of oxycodone is not definitive, even though in the pH range examined, 68-96% of the drug is in the charged form. An expanded range of pH data, particularly down to pH 5.5 (e.g., as with naloxone example below) would be needed to directly address the uptake of the charged form of oxycodone.
3.2. Pentazocine cerebral blood flow rate from pH-dependent Crone-Renkin equation (pH-CRE) applied to Michaelis-Menten analysis
Pentazocine is a lipophilic (log P 3.31, Yokogawa et al., 1990 ) narcotic-antagonist (potent non-addictive analgesic). Two types of rat data are available: (a) carotid injection brain uptake index, BUI (Suzuki et al., 2002a) , and (b) ISBP (Suzuki et al., 2002b) . The opioid is taken up into the brain by an influx transporter mechanism, which can be inhibited by pyrilamine and naloxone (Suzuki et al., 2002a (Suzuki et al., , 2002b . Rodent brain uptake data from the two different methods vs. pH afforded a way to determine the cerebral capillary flow velocity in situ (i.e., pentazocine served as its own flow marker). This newly-determined flow velocity was then applied to the Michaelis-Menten reanalysis of uptake fluxes vs. concentration in the pH 5.5-7.4 interval. Critical to the analysis was the availability of reliably measured pK a values at 37°C. The two values used here (Table 1) were determined by analysis of the 23°C solubility data (Wilson, 1984) , followed by conversion to the physiological temperature . Pentazocine is 100% and 98% positively charged at pH 5.5 and 7.4, respectively. Since the P para predicted by pCEL-X for pentazocine is 0.08 × 10 − 6 cm·s − 1 at the rodent blood-brain barrier (Avdeef, 2012) , paracellular drug diffusion was not considered here. Fig. 3a shows the BUI uptake from a 0.1 mM injectate solution at pH 5.5, 6.5, and 7.4 (circles). Also, BUI uptake was measured from 40 mM solutions at pH 5.5 and 7.4 (squares). Brain concentrations were determined at the end of 15-s injection time (Suzuki et al., 2002a) .
BUI pentazocine data
To test the impact of a re-determined F pf on the uptake kinetics in the BUI method, it was necessary to re-calculate the mean capillary concentrations and the flux values in the Suzuki et al. (2002a) study (J vs. C cap in their published Fig. 3 at pH 5.5 and Fig. 1b at pH 7.4), as described in Section 3.3.
The BUI% values for 0.1 mM injection solutions (C inj ) at pH 5.5, 6.5, and 7.4 ( Fig. 2 in Suzuki et al., 2002a) were converted to K in (mL·s − 1 ·g − 1 ) values (cf., Appendix B). The K in vs. pH values were subjected to pCEL-X analysis, to obtain three pH-CRE parameters: F pf , P 0 , and P + (cf., Abbreviations). The cerebral capillary flow rate was calculated to be F pf = 0.0082 mL·s Pardridge and Fierer, 1985) . The apparent intrinsic permeability (at 0.1 mM) was determined to be 13 × 10
(log S 0 -1.90), which is a higher value than that expected of a passive diffusion process (~3.3 × 10 − 3 cm·s − 1 by pCEL-X in situ brain intrinsic permeability prediction), suggesting that a CM process contribution might be substantial at 0.1 mM. The apparent cationic species permeability, P + , was determined to be 18 × 10 − 6 cm·s − 1 (cf., Eq. (B.10)).
At 0.1 mM C inj , the uptake appears to be flow limited (K in nearly equals the determined F pf in the upper solid curve at pH 7.4, Fig. 3a) . At 0.1 mM injectate, it was assumed that efflux did not affect the calculation of F pf at pH 7.4. At an even lower 0.02 μM perfusate concentration in the ISBP data (below), nearly the same value of F pf was calculated, which suggests that the efflux contribution was relatively small and did not reduce the K in below the estimated flow limit. (A measurement at pH 8.0 would have made the above interpretation more certain.) To examine the pH-dependent uptake under presumably saturating conditions, the BUI% values at the maximum concentration (C inj 40 mM) at pH 5.5 and 7.4 (Suzuki et al., 2002a Figs. 1a and 3, resp.) were also subjected to the pH-CRE analysis. Since only two-pH data were reported, only two parameters could be determined. At 40 mM, the reported permeability values at pH 5.5 and 7.4 were not flow-limited (the limit is reached only for pH > 8.7, lower solid curve in Fig. 3a) . Consequently, the F pf value from the three-point (0.1 mM) calculation was included as a fixed contribution in the 40 mM injectate case, so that P 0 and P + could be determined. The intrinsic and the cationic permeability values under the potentially saturating conditions (lower solid curve in Fig. 3a ) were determined as P 0 = 838 × 10 − 6 (log P 0 − 3.08) and P + = 10 × 10 − 6 cm·s − 1 , respectively. Fig. 3a depicts the results of the pH-CRE analysis. At the 40 mM concentration, the neutral-species CM transport is apparently saturated. This can be surmised from the Michaelis-Menten (MM) analysis of the flow-corrected flux (J) vs. mean capillary concentration (C cap ) data (cf., Section 3.3), where the non-saturable permeability was determined to be k d = 0.030 mL·min − 1 ·g − 1 at pH 7.4 ( Fig. 4b and Table 3 ), which converts to P C = 5 × 10 − 6 cm·s − 1
. The uncertainty in this value is relatively high, due to the scatter of points in Fig. 4b . For example, if Fig. 3 . pH-Dependent Crone-Renkin equation analyses of (a) the in vivo rat carotid artery injection (BUI) data, and (b) the in situ brain perfusion (ISBP) data of pentazocine. The lower (blue) solid curve is the best fit to the data measured at/near saturating levels of injectate (12-40 mM). The upper (red) solid curve represents the assay results at the low injectate concentration, ≤ 0.1 mM, where both influx and efflux transport mechanisms may be operative (Suzuki et al., 2002a (Suzuki et al., , 2002b . Only the low-concentration set indicates a flow limit, with the F pf value of 0.0082 (BUI) and 0.0091 mL·s − 1 ·g − 1 (ISBP). The dashed (neutral) and dash-dot (cation) curves result from the deconvolution of the best-fit solid curves based on the measured points. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) the two highest concentration points in Fig. 4b were not used in the MM regression analysis, then the resultant k d = 0.155 mL·min ), it may be concluded that at 40 mM injectate concentration level, the uptake process predominantly reflects the passive permeability of the uncharged pentazocine, associated with the intrinsic permeability value of log P 0 = − 3.08.
Given that the CM process is saturated for the neutral species at 40 mM injectate concentration, the above passive diffusion intrinsic permeability, P 0 , can be transformed to non-saturable permeability coefficients, k d , at pH 7.4 (0.098 mL·min ). These passive lipoidal values are not expected to be affected by the transporter process. However, the MM analyses of the pH 7.4 and 5.5 flux-concentration data indicate different values Fig. 4. (a, b) The original BUI pentazocine uptake curves (Suzuki et al., 2002a) , flux vs. mean capillary concentration (J vs. C cap ), were re-calculated using the experimental F pf values determined by the pH-Dependent Crone-Renkin equation analysis. The ISBP data (Suzuki et al., 2002b) were similarly treated (see text). The Michaelis-Menten parameters are summarized in Table 3 . The unfilled circles are the reported mean capillary concentrations. The filled-circle data are those calculated after adjustment corrections for the flow determined by the pH-CRE method.
Table 3
Pentazocine Michaelis-Menten analysis of brain uptake in rodent a .
Method pH J max (μmol·min
) GOF n C cap or C pf (mM) CM% NS% Comment CM% = percentage of transport due to saturable carrier-mediated process in the limit of zero concentration. NS% = percentage due to nonsaturable (passive diffusion) process in the limit of zero concentration. C cap = mean capillary concentration of drug (in BUI method), C pf = drug concentration in the perfusion solution (in ISBP method). GOF -goodness-of-fit (cf., Section 2.3); n = number of measurements used in the weighted nonlinear regression analysis. a BUI = brain uptake index (carotid artery injection), ISBP = in situ brain perfusion; J max /K m carrier contribution to flux, in limit of zero concentration.
(0.03 and 0.05 mL·min
, resp.; cf., Table 3 ). Such differences appear to be at odds with the assumptions made in Section 2.4, as discussed below.
It is interesting to note that the weighted MM nonlinear regression analysis to determine the J max , K m , and k d constants indicates very high correlations between these parameters. For example, at pH 7.4: J max and K m , are 95% positively correlated; J max and k d are 96% negatively correlated; K m and k d are 88% negatively correlated. This suggests that the constants are not so uniquely determined and that a range of possible solutions can nearly equally fit the same data. A possible remedy is to refine fewer than three parameters, even though the GOF may increase slightly. We tested this by setting the k d parameter calculated from the P 0 determined by the pH-CRE analysis of the 40 mM data, taking into account the pH dependence (cf., Eq. (A.2) ). The k d was not refined, however. So, only the J max and K m parameters were determined by regression. At pH 7.4, the J max and K m decreased from 4.6 to 2.7 μmol·min − 1 ·g − 1 and 3.3 to 1.4 mM, respectively, as a result of fixing the k d to 0.098 mL·min Table 3 ). The ISBP data showed slight increases in the two refined parameters (Table 3) . Notably, the goodness-of-fit increased from 0.9 to 1.8 (BUI) and from 2.9 to 3.9 (ISBP), as a consequence of entering the fixed value of k d calculated from the pH-CRE P 0 .
The MM-calculated k d value at pH 7.4 would be expected to decrease at pH 5.5, if the non-saturable process involved solely the passive diffusion of the neutral species (cf., assumptions in Section 2.4). But in fact, it increased from 0.03 to 0.05 mL·min ) based on the pH-CRE P 0 was included as a fixed contribution in the pH 5.5 MM analysis, the K m increased 17-fold from 2.4 mM to 40 mM, as J max increased nine-fold from 0.5 to 4.7 μmol·min
, compared to the values at pH 7.4. In effect, the dotted line (PD) in Fig. 4a nearly merged with the horizontal axis, while the dashed (CM) curve nearly merged with the total flux solid curve. The GOF increased only by a small amount (0.8 to 1.1), suggesting that the fit was nearly as good with the fixed k d (determined by the pH-CRE method) compared to when all three MM parameters are simultaneously determined. Section 3.4 further addresses the apparent limitations in the MM analysis applied to the pentazocine data.
ISBP pentazocine data
The ISBP data (Suzuki et al., 2002b) were measured at a flow rate of 3.6 mL·min − 1 , at pH 5.5, 6.5, and 7.4, with uptake determined at several time points over a 30-s interval. Fig. 3b shows the data at 0.02 μM (three filled circles) and 12 mM (two filled squares). Using the pH-CRE method, the cerebral capillary flow rate was calculated as F pf = 0.0091 mL·s
, nearly the same value as determined from BUI data (Section 3.2.1), but still differing from the reported value of 0.0392 mL·s , respectively. These values are consistent with those derived from the BUI data (cf., Fig. 3a and b) . Fig. 4c and d are based on the analysis of the ISBP data. The refined J max , K m , and k d parameters are comparable to those obtained from the BUI data ( Fig. 4a, b ; Table 3 ).
Contribution of carrier-mediated process to overall uptake in the Michaelis-Menten relationship
In the limit of zero perfusate/injectate concentration, the MM equation, Eq. (B.6), may be restated in terms of limiting permeability values, as J/C = J max /K m + k d . The J max /K m term refers to the limiting permeability due to the CM process. In Table 3 , CM% is to the percentage of the CM contribution to the total permeability. In the BUI MM calculation with two refined parameters (k d provided as a fixed contribution) at pH 5.5, 99% of the transport is attributable to the CM process. The value drops to 95% at pH 7.4. This is consistent with increased neutral-species permeation by PD as pH is raised. Pentazocine is 100% charged at pH 5.5 and 98% charged at pH 7.4, which suggests that the pentazocine cation is the predominant substrate for the transporter across the entire pH range studied. Even at the 40 mM injectate level, the CM uptake of the pentazocine cation in not fully saturated. Under these conditions, the neutral species only permeates by lipoidal passive diffusion.
3.3. Re-calculation of the pentazocine uptake curves (J vs. C cap ) as a result of the newly-determined F pf
The procedure for extracting from the reported uptake data the legacy value of F pf and replacing it with the value determined by the Crone-Renkin-pH analysis is described here for the pH 7.4 flux (J) vs. C cap profile (Fig. 1b in Suzuki et al., 2002a) . The theoretical relationships used are described in Appendix B. First, the original C inj values were digitized from the published Fig. 1a (BUI% vs. C inj ) . Also, values of C cap , J, and standard deviations (SD) were digitized from the published Fig. 1b (J vs. C cap ) . The original flow-corrected PS values were calculated as J/C cap . From these, the flow-uncorrected K in values were determined using Eq. (B.3), where the assumed legacy value of F pf = 0.0155 mL·s − 1 ·g − 1 had been applied in the case of the BUI data.
This, in effect, "de-corrected" the original uptake data for flow. 
Limitations in the Michaelis-Menten analysis
The inconsistencies between the k d values calculated by the MM and the pH-CRE analyses may be due to the high correlations between the three refined MM parameters, and also of the way the MM equation is defined when ionizable molecules are considered. The concentration term in the MM equation, Eq. (B.6), does not explicitly specify the charge state of the ionizable drug evaluated. It is evident at pH 5.5 in Fig. 3 that the cation is taken up by a saturable process (i.e., K in increases as concentration decreases). The points at pH 5.5 lie along the hyperbolic dash-dot cation species curves (CM only), and are well above the parabolic neutral species dashed curves at pH 5.5 (neutral species: CM and PD at 0.1 mM, but only PD at 40 mM). It is also evident from the pH-CRE analysis that the predicted dashed curves at pH 9.5 indicate a saturable process that affects the neutral species (apparent P 0 increases with decreasing drug concentration). Appendix B considers possible further expansions of the MM equation to take into account the ionization constants of the drug. The naloxone data below tested the idea of pH-dependent MM analysis.
Naloxone cerebral blood flow rate from pH-dependent Crone-Renkin equation (pH-CRE)
Naloxone is a potent opioid antagonist, which can permeate the BBB at nearly ten times the rate of morphine (Suzuki et al., 2010a) . A mechanism consisting of both passive diffusion and a CM uptake was proposed by the investigators. The saturable process is strongly inhibited by cationic H 1 -antagonists, e.g., pyrilamine. Unlike pentazocine considered above, naloxone is apparently not a substrate for P-gp (Suzuki et al., 2010b) . The moderately lipophilic ampholytic drug naloxone (log P 1.81, Kansy et al., 2001) , with pK a 9.25 and 7.82 at 37°C (Kaufman et al., 1975) , was critically examined by Suzuki et al. (2010a) , using the BUI method. At pH 7.4, the flux at ten different concentrations (0.5 μM-15 mM) was reported. In addition, 0.1 μM carotid artery injection (BUI) measurements were performed at pH 5. 5, 6.0, 6.5, 7.0, 7.4, 8.0, and 8.5 . Furthermore, 10 mM injection measurements were performed at pH 5.5, 6.0, 6.5, 7.0, and 7.4. As far as we are aware, this unique study represents the largest range of pH used for BBB permeability measurement in the literature. The data appear to be of high quality. Thus, there was an opportunity to extract additional insights into the nature of the rate of naloxone BBB penetration and how it depends on pH, by applying the pH-CRE and pH-MME analyses (cf., Appendix B).
The re-analysis started with the conversion of the BUI-pH data (Fig. 2 in Suzuki et al., 2010a) into log (K in /S)-pH data format accepted by the pCEL-X program. It was possible to obtain three constants by the weighted regression procedure. For the 0.1 μM set: F pf = 0.0055 ± 0.0001 mL·s − 1 ·g − 1 , log P 0 = − 3.69 ± 0.04 (cm·s ), GOF = 0.29, n = 5. Fig. 5 shows the best-fit (solid) curves for the two sets of data, with the filled circles and squares representing the 0.1 μM and 10 mM sets, respectively. The (flow-corrected) neutral-species (pH-partition hypothesis) log P C parabolic curves are represented by short and long dashes for the 0.1 μM and 10 mM sets, respectively. The flow-corrected ionic-species log P i hyperbolic curves are represented by the two dashdot curves. The flow velocities refined to identical F pf values for the two sets. These are indicated by the dotted horizontal line.
Next, the flux-concentration data ( Fig. 1 in Suzuki et al., 2010a) were evaluated using the MM equation. The flux and mean capillary values were re-calculated according to the newly determined pH-CRE F pf value, following a procedure similar to that described for pentazocine above (Section 3.3). ; GOF = 2.5, n = 10. The non-saturable k d parameter obtained, 0.12 mL·min − 1 ·g − 1 , was converted to the equivalent P C value at pH 7.4, from which the whole log P C curve was calculated, with knowledge of the pK a values, and is shown in Fig. 5 as the dash-dot-dot parabolic curve. Some interesting conclusions can be derived from the inspection of Fig. 5 . The three parabolic curves have a systematic dependence on concentration, suggesting that the neutral ampholyte is a substrate for an influx transporter. At 10 mM concentration, the process is not entirely saturated, since the k d -derived curve is lower than that indicated by the 10 mM data (middle parabolic curve). It is reasonable to assume that the intrinsic permeability derived from the MM analysis k d , P 0 = 74 × 10 − 6 cm·s − 1 , describes the passive transport process. This is not far from the pCEL-X prediction of the naloxone passive in situ brain perfusion, P 0~2 56 × 10 − 6 cm·s − 1 (cf., Tsinman et al., 2011 ).
Naloxone: pH-dependent Michaelis-Menten equation (pH-MME) analysis
Assuming that the passive intrinsic permeability, P 0 , determined from the MM analysis k d value from pH 7.4 data can be used to predict the k d values at other pH values (cf., Eq. (A.2) and Section 2.4), it seemed possible that two-point Michaelis-Menten analysis could be used to determine J max and K m at each of the pH values from 5.5 to 8.5, provided a value of k d (pH-dependent) is included as a fixed contribution at each pH in the MM analysis. The missing 10 mM data at pH 8.0, 8.5 were approximated according to the lower solid curve in Fig. 5 . The pH-MME procedure is further discussed in Section B.4. Fig. 7 summarizes such a pH-MME analysis. It appears that two uptake mechanisms may be operating across the pH range (Fig. 7a) : a higher capacity uptake process affecting the naloxone cation in the range pH 5.0-7.0 (J max~3 .2 μmol·min − 1 ·g − 1 , K m~1 4 mM) and a lower capacity uptake process affecting the neutral drug in the pH 8.0-8.5 range (J max~0 .5 μmol·min − 1 ·g − 1 , K m~3 mM). Consistent with this, the percentage of CM contribution (Fig. 7b) to the overall transport is greater in the region of the cationic transporter (pH 5.5) than that of the neutral transporter (pH 8.5). This can be interpreted as the action of a single transporter which has different specificities for the two charge forms of naloxone. 
Conclusions
This study has shown that careful analysis of BBB permeability data, obtained from both in situ brain perfusion (ISBP) and carotid injection (BUI) techniques and using a range of experimental pH, can reveal important additional information not obvious from the original published reports. The computation tool pCEL-X was instrumental in the calculations involved, and the internal consistency of the analysis adds to evidence for the reliability and accuracy of the methods. Notable findings were improved estimates of F pf for both ISBP and BUI, and resolution of CM components of permeability for all three compounds examined: oxycodone, pentazocine and naloxone. It is clear from this post hoc analysis that even better understanding of underlying mechanisms would have been possible had the proposed experimental conditions been tested in advance (or at an early stage), using pCEL-X to establish the optimal pH and concentration ranges for experiments. Furthermore, introducing relevant inhibitors once CM was detected would have permitted valuable confirmation of the CM components deduced. In conclusion, this study shows the value of combining BBB permeability studies under a range of pH and concentration conditions, to improve the accuracy of derived numerical data, and to reveal underlying physiological mechanisms and kinetics of carriermediated transport.
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Appendix A. In vitro flat monolayer permeability model
The description of the in vitro cell permeability biophysical analysis is first presented (Yusof et al., 2014; Avdeef et al., 2015) , since it is the basis of the capillary in vivo permeability data analysis. The in vitro apparent endothelial permeability, P app , may be deconvolved into its four underlying components: P ABL , P filter , P C , and P para (aqueous boundary layer, filter, transendothelial cell membrane, and paracellular, respectively -cf., Abbreviations),
The planar monolayer model is illustrated in Fig. 1 (dash-dot-dot curve above and solid curve below ) in the logarithmic form of Eq. (A.1). The capillary flow model is indicated by the thick solid curve in the figure. The other curves are identified and the figure caption and are discussed below. (The filter contribution is not indicated in Fig. 1 for the planar model.) 
A.1. Transcellular permeability
For a monoprotic ionizable molecule, the transcellular permeability, P C , describes the neutral-species permeability (pH-partition hypothesis) and is defined by S.R. Yusof et al. European Journal of Pharmaceutical Sciences 106 (2017) 274-286 
where the '+' in ' ± ' is used for acids and the '−' is used for bases. For a two-pK a ampholyte, the denominator term becomes 10 + pKa1 -pH + 10 -pKa2 + pH + 1, where pK a1 < pK a2 . The dashed curve in Fig. 1 indicates the hyperbolic log P C -pH profile. The intrinsic permeability, P 0 , is indicated at the top of the curve, at the pH where the molecule is fully uncharged. The log (P C + P para ) vs. pH curve is expected to be sigmoidal in shape (dashed curve above and solid curve below for the planar model). Its minimum possible value is the paracellular permeability. In a purely passive diffusion (PD) process, the transcellular permeability denotes non-saturable lipoidal permeability of the apical, basolateral, and cytosolic-organelle membranes. But saturable carrier-mediated (CM) processes may exist in parallel with the non-saturable PD processes.
A.2. Paracellular permeability
In Eq. (A.1), the dual-pore population paracellular equation (Avdeef and Tam, 2010 ) is defined as
The paracellular junction porosity divided by the pore pathlength is indicated by ε/δ. The last term in Eq. (A.3) describes the secondary size/ charge-nonspecific "free diffusion" pathway contribution. The E(Δφ) term is a function of the potential drop, Δφ, across the electric field created by negatively-charged residues lining the junction pores. F(r/R) is the Renkin hydrodynamic sieving function (Ho et al., 2000) for cylindrical water channels, defined as a function of the molecular hydrodynamic radius (r) and junction pore radius (R), both usually expressed in Å units. D aq (cm 2 ·s − 1 ) is the aqueous diffusivity of the solute at 37°C (related to molecular weight (Avdeef, 2012) ). Typical values of the paracellular parameters have been tabulated for several in vitro cultured cells (Avdeef, 2010 (Avdeef, , 2011 .
A.3. Filter porosity permeability
In Eq. (A.1), P f is the filter-porosity permeability, defined as.
where ε f is the filter porosity fraction, which for Transwell™ filters comes in values from 0.003-0.008 ('clear filters', polyethylene) to 0.13-0.20 ('translucent filters', polycarbonate) (Yusof et al., 2014) ; h f is the thickness of the filter (10 μm for polycarbonate). For a molecule with molecular weight 300 Da and a polycarbonate filter with 0.135 porosity, the predicted P filter = 1079 × 10
. However, if a clear plastic polyethylene filter is used, with porosity 0.005, then P filter = 40 × 10 − 6 cm s
. Hence, clear filters generally are not suitable for in vitro measurements of highlypermeable drugs.
A.4. Aqueous Boundary Layer (ABL) Permeability
In ordinary applications of Eq. (A.1), the aqueous boundary layer (ABL) permeability is defined as.
where h ABL is the ABL thickness in the in vitro cell assay, which can be predicted from the stirring rate or by the pK a flux method (Avdeef et al., 2005; Yusof et al., 2014 (Terasaki et al., 1986) . At 15-s post-injection (in the case study examples considered here), the animal is sacrificed; the drug and reference concentrations in the brain are then determined. The brain uptake rate (flux per g of brain tissue), J may be defined as
where C inj (mM) is the injectate drug concentration, C cap (mM) is the mean capillary drug concentration, F pf is the cerebral blood flow rate, and PS is the permeability-surface product. The injectate concentration (C inj ) is usually greater than the capillary (C cap ) value, especially when substantial extraction occurs.
B.2. Crone-Renkin equation (CRE)
Related to the BUI is the transfer constant for the initial brain transport (clearance) of the drug,
, which reflects the unidirectional transport at the luminal BBB membrane (not corrected for flow). In the in situ brain perfusion method, the transfer constant is often defined operationally as K in = (Q br /C pf )/T, where Q br = test compound parenchymal brain concentration (nmol·g K in /S = P app (solid curve in Fig. 1 ), whereas PS/S is the flow-corrected P C (dashed curve above and solid curve below in Fig. 1 ). When permeability is not limited by flow, PS = K in . The endothelial luminal permeability, the 'P' in PS, is defined below (Eqs. (B.8) and (B.9) ). The rat brain endothelial surface area (per gram of brain tissue), S (cm
, is often approximated to be 100 cm 2 •g − 1 (Ohno et al., 1978) . From Eqs. (B.2) and (B.3), the relationship between the C inj and C cap may be stated as.
According to the transposed CRE from Eq. (B.3),
B.3. Michaelis-Menten equation (MME)
When carrier-mediated transport is evident, the Michaelis-Menten equation (MME) can be used to separate the saturable from the non-saturable (usually passive) components of transport,
where J max (μmol·min ) represent the maximal transport rate of the saturable uptake, the half-saturation concentration (Michaelis constant), and the non-saturable uptake first-order rate constant, respectively. It is very important that the fit be weighted, based on reported experimental errors in the flux values. Using unit weights produces a significantly-different set of MM parameters.
B.4. pH-Dependent Michaelis-Menten equation (pH-MME)
When a transporter acts with different specificity for the charged and the neutral forms of a drug, the MME may be expanded to the pH-dependent form, pH-MME, as The first term addresses the cationic-species CM process, while the second term addresses the neutral-species CM process. The fraction of the compound in the neutral form is denoted as f 0 = 1/(10 ± (pH-pKa) + 1) for a monoprotic drug and f 0 = 1/(10 + pKa1-pH + 10 -pKa2 + pH + 1) for a twopK a ampholyte, where pK a1 < pK a2 . In addition to CM uptake, the contribution from efflux would require further expansions (Bentz et al., 2005) , but this was not considered here.
B.5. pH-Dependent Crone-Renkin equation for flow correction
If K in (or k d ) of an ionizable drug (with acid pK a < 9 or base pK a > 5) were measured at more than one pH, F pf could be determined without the use of a standard flow marker, such as diazepam (Smith, 2003) ('−' sign for bases and the '+' sign for acids). The first term in Eq. (B.8) refers to the capillary flow "resistance," while the second term refers to the endothelial cell "resistance," comprising the transcellular (P C and P i ) and paracellular (P para ) contributions. Eq. (B.8) is the "monolayer" approximation to the flow equation described below. The small differences between the exact capillary tubular flow (solid line in Fig. 1 ) and planar monolayer (dash-dot-dot line in Fig. 1 ) models are evident near the bend in the curve where the horizontal flow limit (dotted line) and the diagonal transcellular (dashed line) curves intersect, as indicated by pK a flux in Fig. 1 . For a monoprotic acid or base, the relationship between the effective luminal permeability, P app , and pH can be stated as a sum of three permeability components -(i) neutral species (P C ) curve, (ii) charged species (P i ) curve, as in case of carrier-mediated effects, and (iii) leaked species through paracellular water-filled pores in the tight junctions between endothelial cells (P para ). Normally, paracellular junctions at the BBB are very tight (cf., BBB paracellular parameters in Eq. (A.3) above). For the rodent BBB, the empirical parameters have been estimated as ε/δ = 6.7 ± 4.5 cm − 1 , R = 4.8 ± 0.4 Å, ε/δ 2 = 0.009 ± 0.017 cm − 1 (Avdeef, 2012) . For example, the predicted BBB paracellular permeability of sucrose is predicted to be P para sucrose = 0.07 × 10 − 6 cm • s − 1
. In many cases, P i can be S.R. Yusof et al. European Journal of Pharmaceutical Sciences 106 (2017) 274-286 neglected, unless the charged form of the drug is a substrate of a carrier-mediated transport. The above pH-CRE flow correction method can be applied to a flow-or near flow-limited ionizable drug (whose pK a value is known at 37°C ). Ideally, K in is measured in at least two different pH buffers in the pH 5.5-8.5 range. At least one point ( in Fig. 1) needs to be at a pH where the molecule is nearly uncharged and P C is high (near or exceeding the flow limit), and one point ( in Fig. 1 ) needs to be at the pH where the molecule is partly charged and P C is lower (sufficiently below the flow limit). If ionic-species transport exceeding paracellular permeability is suspected (e.g., by a bend in the log P app -pH curve in Fig. 1 near pH 5.5) , then at least a third K in needs to be measured ( in Fig. 1) . The computational method does not require an external flow calibrant like diazepam. Moreover, the drug chosen for the pH-CRE analysis can also serve as a suitable substitute for diazepam in the traditional CRE method, since the value of F pf is also determined by the pH-CRE analysis. Perhaps the most important use of the pH-CRE is to obtain a relevant in vivo dataset for validating in vitro assays, which is challenging to do for lipophilic drugs by traditional techniques.
